![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/LAURUSLABS.png)
Share the post "Laurus Labs ‘s Q3 2024-25 Latest News: Revenue Rises by 18.42% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 18.42 % in the past year, substantial increase in net sales/revenue by 15.64 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 287.65 %. Marginal increase in other income during this quarter, up by 104.78%. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Laurus Labs Limited. Notable increase of 298.2 % in net profit Year to Year, Laurus Labs Limited’s profitability increased by 365.86 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 297.67 % Year to Year. EPS increased by 362.16 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1194.92 Cr | Rs. 1223.7 Cr | Rs. 1415.05 Cr | + 15.64 % | + 18.42 % |
| Expenses | Rs. 1015.33 Cr | Rs. 1045.37 Cr | Rs. 1129.9 Cr | + 8.09 % | + 11.28 % |
| Operating Profit | Rs. 179.59 Cr | Rs. 178.33 Cr | Rs. 285.15 Cr | + 59.9 % | + 58.78 % |
| OPM % | 15.03 % | 14.57 % | 20.15 % | + 5.58 % | + 5.12 % |
| Other Income | Rs. 2.43 Cr | Rs. 4.6 Cr | Rs. 9.42 Cr | + 104.78 % | + 287.65 % |
| Interest | Rs. 50.82 Cr | Rs. 52.61 Cr | Rs. 57.8 Cr | + 9.87 % | + 13.73 % |
| Depreciation | Rs. 98.41 Cr | Rs. 107.51 Cr | Rs. 106.09 Cr | -1.32 % | + 7.8 % |
| Profit before tax | Rs. 32.79 Cr | Rs. 22.81 Cr | Rs. 130.68 Cr | + 472.91 % | + 298.54 % |
| Tax % | 27.3 % | 22.31 % | 30.66 % | + 8.35 % | + 3.36 % |
| Net Profit | Rs. 23.34 Cr | Rs. 19.95 Cr | Rs. 92.94 Cr | + 365.86 % | + 298.2 % |
| EPS in Rs | Rs. 0.43 | Rs. 0.37 | Rs. 1.71 | + 362.16 % | + 297.67 % |
Today, we’re looking at Laurus Labs Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 18.42 %. However, it did see a marginal increase of 15.64 % from the previous quarter. Expenses ticked up slightly by 8.09 % quarter-on-quarter, aligning with the annual rise of 11.28 %. Operating profit, while up 58.78 % compared to last year, faced a quarter-on-quarter increase of 59.9 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 5.12 %, but an expansion of 5.58 % sequentially. Other income rose by 104.78 % compared to the last quarter, despite an annual growth of 287.65 %. Interest expenses surged remarkably by 9.87 % from the previous quarter, yet the year-over-year increase remains at a moderate 13.73 %. Depreciation costs fell by -1.32 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 7.8 %. Profit before tax grew annually by 298.54 % but saw an increase from the preceding quarter by 472.91 %.
Tax expenses as a percentage of profits increased slightly by 3.36 % compared to last year, with a more notable quarter-on-quarter increase of 8.35 %. Net profit rose by 298.2 % year-on-year but experienced a 365.86 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 297.67 % but a quarterly rise of 362.16 %. In summary, Laurus Labs Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1194.92 Cr | Rs. 1223.7 Cr | Rs. 1415.05 Cr | + 15.64 % | + 18.42 % |
| Expenses | Rs. 1015.33 Cr | Rs. 1045.37 Cr | Rs. 1129.9 Cr | + 8.09 % | + 11.28 % |
| Operating Profit | Rs. 179.59 Cr | Rs. 178.33 Cr | Rs. 285.15 Cr | + 59.9 % | + 58.78 % |
| Net Profit | Rs. 23.34 Cr | Rs. 19.95 Cr | Rs. 92.94 Cr | + 365.86 % | + 298.2 % |
| EPS in Rs | Rs. 0.43 | Rs. 0.37 | Rs. 1.71 | + 362.16 % | + 297.67 % |
In reviewing Laurus Labs Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 18.42 % year-on-year growth, however, there was a minor increase of 15.64 % from the previous quarter. Expenses rose by 11.28 % compared to the previous year, with a 8.09 % increase quarter-on-quarter. Operating Profit surged by 58.78 % annually, and saw a 59.9 % increase from the last quarter.
Net Profit showed yearly increase of 298.2 %, and experienced a 365.86 % increase from the previous quarter. Earnings Per Share (EPS) rose by 297.67 % annually, however rose by 362.16 % compared to the last quarter. In essence, while Laurus Labs Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/INDRAIND.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/PTL.png)